BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 30995501)

  • 1. Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines.
    Murakami M; Kamimura D; Hirano T
    Immunity; 2019 Apr; 50(4):812-831. PubMed ID: 30995501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
    Hirano T; Matsuda T; Nakajima K
    Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
    Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 6 and its receptor: ten years later.
    Hirano T
    Int Rev Immunol; 1998; 16(3-4):249-84. PubMed ID: 9505191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of cytokine receptor function by gene manipulation].
    Taga T
    Nihon Rinsho; 1998 Jul; 56(7):1674-80. PubMed ID: 9702036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasticity and cross-talk of interleukin 6-type cytokines.
    Garbers C; Hermanns HM; Schaper F; Müller-Newen G; Grötzinger J; Rose-John S; Scheller J
    Cytokine Growth Factor Rev; 2012 Jun; 23(3):85-97. PubMed ID: 22595692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical overview of the interleukin-6 family cytokine.
    Kang S; Narazaki M; Metwally H; Kishimoto T
    J Exp Med; 2020 May; 217(5):. PubMed ID: 32267936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF.
    Liu F; Aubin JE; Malaval L
    Bone; 2002 Jul; 31(1):212-9. PubMed ID: 12110437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family.
    Murakami M; Narazaki M; Hibi M; Yawata H; Yasukawa K; Hamaguchi M; Taga T; Kishimoto T
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11349-53. PubMed ID: 1662392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The interleukin-6 signal transducer, gp130, functioning in immune, hematopoietic, and neural systems].
    Taga T
    Nihon Rinsho; 1992 Aug; 50(8):1802-10. PubMed ID: 1433971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of IL-6 type cytokines and their receptors in bone.
    Manolagas SC
    Ann N Y Acad Sci; 1998 May; 840():194-204. PubMed ID: 9629251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 and its receptor: a paradigm for cytokines.
    Kishimoto T; Akira S; Taga T
    Science; 1992 Oct; 258(5082):593-7. PubMed ID: 1411569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gp130 and the interleukin-6 family of cytokines.
    Taga T; Kishimoto T
    Annu Rev Immunol; 1997; 15():797-819. PubMed ID: 9143707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and related cytokines: effect on the acute phase reaction.
    Heinrich PC; Horn F; Graeve L; Dittrich E; Kerr I; Müller-Newen G; Grötzinger J; Wollmer A
    Z Ernahrungswiss; 1998; 37 Suppl 1():43-9. PubMed ID: 9558728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 trans-signalling in chronic inflammation and cancer.
    Scheller J; Ohnesorge N; Rose-John S
    Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paradigm of IL-6: from basic science to medicine.
    Naka T; Nishimoto N; Kishimoto T
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S233-42. PubMed ID: 12110143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.
    Taga T; Narazaki M; Yasukawa K; Saito T; Miki D; Hamaguchi M; Davis S; Shoyab M; Yancopoulos GD; Kishimoto T
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10998-1001. PubMed ID: 1438305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.